Well..the 1991 study should really be null as that was about the time that
Parlodel was DC in US.
The 1996 study is referring to a pathological medical condition, NOT normal
lactation!  So I don't think it is valid to transfer the info from an
abnormal condition to a normal physiologic process.  Both of Hale's ref are
1991 too.
 Is anyone aware if Dostinex is being used in USA for purpose of inhibiting
normal lactation?
The other issue is using scarey stuff to suppress something that will just
go away with tincture of time (if you don't want it :-(  Sincerely, Pat in
SNJ

>
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

> ds=8713691&dopt=Abstract
> Drug Saf 1996 Apr;14(4):228-38
> A comparative review of the tolerability profiles of dopamine agonists in
> the treatment of hyperprolactinaemia and inhibition of lactation.
> Webster J
>
>
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

> ds=1676318&dopt=Abstract
> : BMJ 1991 Jun 8;302(6789):1367-71
> Single dose cabergoline versus bromocriptine in inhibition of puerperal
> lactation: randomised, double blind, multicentre study. European
Multicentre
> Study Group for Cabergoline in Lactation Inhibition.

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html